| Isotretinoin | Approved Investigational | NTAN1 | 123803 |
downregulated | Isotretinoin results in decreased expression of NTAN1 mRNA | 16p13.11 | |
| Isotretinoin | Approved Investigational | NTRK2 | 4915 |
upregulated | Isotretinoin results in increased expression of NTRK2 mRNA | 9q21.33 | |
| Isotretinoin | Approved Investigational | NUDT21 | 11051 |
downregulated | Isotretinoin results in decreased expression of NUDT21 mRNA | 16q13 | |
| Isotretinoin | Approved Investigational | NUDT4 | 11163 |
downregulated | Isotretinoin results in decreased expression of NUDT4 mRNA | 12q22 | |
| Isotretinoin | Approved Investigational | NUS1P3 | 11049 |
downregulated | Isotretinoin results in decreased expression of NUS1P3 mRNA | 13q12.12 | |
| Isotretinoin | Approved Investigational | OAS1 | 4938 |
downregulated | Isotretinoin results in decreased expression of OAS1 mRNA | 12q24.2 | |
| Isotretinoin | Approved Investigational | ODC1 | 4953 |
downregulated | Isotretinoin results in decreased expression of ODC1 mRNA | 2p25.1 | |
| Isotretinoin | Approved Investigational | OLAH | 55301 |
downregulated | Isotretinoin results in decreased expression of OLAH mRNA | 10p13 | |
| Isotretinoin | Approved Investigational | OR7E12P | 10821 |
downregulated | Isotretinoin results in decreased expression of OR7E12P mRNA | 11p15.4 | |
| Isotretinoin | Approved Investigational | ORMDL2 | 29095 |
downregulated | Isotretinoin results in decreased expression of ORMDL2 mRNA | 12q13.2 | |
| Isotretinoin | Approved Investigational | OTUB2 | 78990 |
downregulated | Isotretinoin results in decreased expression of OTUB2 mRNA | 14q32.12 | |
| Isotretinoin | Approved Investigational | PAFAH2 | 5051 |
downregulated | Isotretinoin results in decreased expression of PAFAH2 mRNA | 1p36.11 | |
| Isotretinoin | Approved Investigational | PANK3 | 79646 |
downregulated | Isotretinoin results in decreased expression of PANK3 mRNA | 5q34 | |
| Isotretinoin | Approved Investigational | PAQR3 | 152559 |
downregulated | Isotretinoin results in decreased expression of PAQR3 mRNA | 4q21.21 | |
| Isotretinoin | Approved Investigational | PAWR | 5074 |
downregulated | Isotretinoin results in decreased expression of PAWR mRNA | 12q21.2 | |
| Isotretinoin | Approved Investigational | PCCB | 5096 |
downregulated | Isotretinoin results in decreased expression of PCCB mRNA | 3q22.3 | |
| Isotretinoin | Approved Investigational | PCOLCE | 5118 |
upregulated | Isotretinoin results in increased expression of PCOLCE mRNA | 7q22.1 | |
| Isotretinoin | Approved Investigational | PCTP | 58488 |
downregulated | Isotretinoin results in decreased expression of PCTP mRNA | 17q22 | |
| Isotretinoin | Approved Investigational | PDE6A | 5145 |
downregulated | Isotretinoin results in decreased expression of PDE6A mRNA | 5q32 | |
| Isotretinoin | Approved Investigational | PDGFRB | 5159 |
upregulated | Isotretinoin results in increased expression of PDGFRB mRNA | 5q32 | |
| Isotretinoin | Approved Investigational | PDHA1 | 5160 |
downregulated | Isotretinoin results in decreased expression of PDHA1 mRNA | Xp22.12 | |
| Isotretinoin | Approved Investigational | PDHB | 5162 |
downregulated | Isotretinoin results in decreased expression of PDHB mRNA | 3p14.3 | |
| Isotretinoin | Approved Investigational | PDHX | 8050 |
downregulated | Isotretinoin results in decreased expression of PDHX mRNA | 11p13 | |
| Isotretinoin | Approved Investigational | PDXK | 8566 |
downregulated | Isotretinoin results in decreased expression of PDXK mRNA | 21q22.3 | |
| Isotretinoin | Approved Investigational | PDZK1 | 5174 |
downregulated | Isotretinoin results in decreased expression of PDZK1 mRNA | 1q21.1 | |